V Square Quantitative Management LLC Grows Stock Holdings in Mettler-Toledo International Inc. (NYSE:MTD)

V Square Quantitative Management LLC boosted its stake in Mettler-Toledo International Inc. (NYSE:MTDFree Report) by 4.1% during the 3rd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 505 shares of the medical instruments supplier’s stock after acquiring an additional 20 shares during the period. V Square Quantitative Management LLC’s holdings in Mettler-Toledo International were worth $757,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. PineStone Asset Management Inc. increased its holdings in shares of Mettler-Toledo International by 127.4% in the second quarter. PineStone Asset Management Inc. now owns 259,629 shares of the medical instruments supplier’s stock valued at $362,855,000 after purchasing an additional 145,453 shares during the period. Capital International Investors increased its stake in Mettler-Toledo International by 15.1% in the 1st quarter. Capital International Investors now owns 1,075,420 shares of the medical instruments supplier’s stock valued at $1,431,696,000 after buying an additional 141,431 shares during the period. Price T Rowe Associates Inc. MD raised its position in Mettler-Toledo International by 88.3% during the 1st quarter. Price T Rowe Associates Inc. MD now owns 122,655 shares of the medical instruments supplier’s stock worth $163,290,000 after buying an additional 57,509 shares during the last quarter. TD Asset Management Inc lifted its stake in shares of Mettler-Toledo International by 53.1% in the 1st quarter. TD Asset Management Inc now owns 154,381 shares of the medical instruments supplier’s stock worth $205,526,000 after acquiring an additional 53,561 shares during the period. Finally, Massachusetts Financial Services Co. MA boosted its holdings in shares of Mettler-Toledo International by 32.5% in the second quarter. Massachusetts Financial Services Co. MA now owns 142,944 shares of the medical instruments supplier’s stock valued at $199,777,000 after acquiring an additional 35,048 shares in the last quarter. 95.07% of the stock is owned by hedge funds and other institutional investors.

Insiders Place Their Bets

In related news, insider Christian Magloth sold 1,000 shares of the stock in a transaction on Thursday, August 15th. The stock was sold at an average price of $1,422.97, for a total transaction of $1,422,970.00. Following the sale, the insider now owns 734 shares of the company’s stock, valued at $1,044,459.98. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. In other Mettler-Toledo International news, insider Christian Magloth sold 1,000 shares of the company’s stock in a transaction dated Thursday, August 15th. The shares were sold at an average price of $1,422.97, for a total value of $1,422,970.00. Following the transaction, the insider now directly owns 734 shares in the company, valued at approximately $1,044,459.98. This represents a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, CFO Shawn Vadala sold 250 shares of Mettler-Toledo International stock in a transaction dated Wednesday, August 7th. The stock was sold at an average price of $1,401.00, for a total transaction of $350,250.00. Following the sale, the chief financial officer now owns 4,914 shares of the company’s stock, valued at approximately $6,884,514. This trade represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 1.94% of the stock is currently owned by company insiders.

Mettler-Toledo International Trading Up 0.7 %

Shares of NYSE MTD opened at $1,373.98 on Friday. The company’s 50-day moving average price is $1,424.61 and its 200 day moving average price is $1,393.22. Mettler-Toledo International Inc. has a 52 week low of $928.49 and a 52 week high of $1,546.93. The stock has a market cap of $29.34 billion, a price-to-earnings ratio of 38.53, a PEG ratio of 4.24 and a beta of 1.14.

Mettler-Toledo International (NYSE:MTDGet Free Report) last released its quarterly earnings results on Thursday, August 1st. The medical instruments supplier reported $9.65 EPS for the quarter, beating the consensus estimate of $9.00 by $0.65. Mettler-Toledo International had a net margin of 20.95% and a negative return on equity of 575.61%. The business had revenue of $946.75 million for the quarter, compared to analyst estimates of $929.13 million. During the same period in the prior year, the business earned $10.19 earnings per share. The company’s quarterly revenue was down 3.6% on a year-over-year basis. As a group, research analysts expect that Mettler-Toledo International Inc. will post 40.35 earnings per share for the current year.

Analysts Set New Price Targets

A number of brokerages recently commented on MTD. StockNews.com upgraded shares of Mettler-Toledo International from a “hold” rating to a “buy” rating in a research report on Thursday, July 11th. Wells Fargo & Company assumed coverage on Mettler-Toledo International in a research note on Tuesday, August 27th. They issued an “equal weight” rating and a $1,400.00 price target on the stock. JPMorgan Chase & Co. increased their price objective on Mettler-Toledo International from $1,300.00 to $1,400.00 and gave the stock a “neutral” rating in a research report on Monday, August 5th. The Goldman Sachs Group boosted their target price on shares of Mettler-Toledo International from $1,150.00 to $1,300.00 and gave the stock a “neutral” rating in a research report on Tuesday, July 9th. Finally, Stifel Nicolaus increased their price target on shares of Mettler-Toledo International from $1,510.00 to $1,550.00 and gave the company a “buy” rating in a report on Monday, August 5th. Two research analysts have rated the stock with a sell rating, five have given a hold rating and two have issued a buy rating to the company. According to MarketBeat, Mettler-Toledo International has a consensus rating of “Hold” and an average target price of $1,363.75.

View Our Latest Analysis on Mettler-Toledo International

Mettler-Toledo International Company Profile

(Free Report)

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.

Featured Stories

Want to see what other hedge funds are holding MTD? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Mettler-Toledo International Inc. (NYSE:MTDFree Report).

Institutional Ownership by Quarter for Mettler-Toledo International (NYSE:MTD)

Receive News & Ratings for Mettler-Toledo International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mettler-Toledo International and related companies with MarketBeat.com's FREE daily email newsletter.